{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:43:20Z","timestamp":1788443000887,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e27840","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T04:19:34Z","timestamp":1710389974000},"page":"e27840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of sodium\/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the \u03b2-catenin\/LEF-1 pathway"],"prefix":"10.1016","volume":"10","author":[{"given":"Nan-Fang","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Kun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.21147\/j.issn.1000-9604.2019.01.09","article-title":"Incidence and mortality of thyroid cancer in China, 2008\u2212 2012","volume":"31","author":"Du","year":"2019","journal-title":"Chin. J. Cancer Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27840_bib2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ijc.33298","article-title":"Screening and the epidemic of thyroid cancer in China: an analysis of national representative inpatient and commercial insurance databases","volume":"148","author":"Liu","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27840_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12020-020-02230-7","article-title":"Time trend analysis of thyroid cancer surgery in China: single institutional database analysis of 15,000 patients","volume":"68","author":"Sui","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.heliyon.2024.e27840_bib4","first-page":"2018","article-title":"Clinicopathological and survival outcomes of well-differentiated thyroid carcinoma undergoing dedifferentiation: a retrospective study from FUSCC","author":"Ma","year":"2018","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12022-021-09665-2","article-title":"Molecular pathology of poorly differentiated and anaplastic thyroid cancer: what do pathologists need to know?","volume":"32","author":"Volante","year":"2021","journal-title":"Endocr. Pathol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-022-00382-4","article-title":"MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer","volume":"10","author":"Hamidi","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.heliyon.2024.e27840_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijsu.2018.06.001","article-title":"Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: a retrospective cohort study of 4,683 patients","volume":"55","author":"Hong","year":"2018","journal-title":"Int. J. Surg."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50913-7","article-title":"LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer","volume":"9","author":"Luz\u00f3n-Toro","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27840_bib9","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/cas.14389","article-title":"Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis","volume":"111","author":"Lan","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.heliyon.2024.e27840_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.109085","article-title":"Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks","volume":"715","author":"Gulfidan","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1530\/EC-17-0302","article-title":"NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features","volume":"7","author":"Tavares","year":"2018","journal-title":"Endocrine connections"},{"key":"10.1016\/j.heliyon.2024.e27840_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9128754","article-title":"The role of the NIS (SLC5A5) gene in papillary thyroid cancer: a systematic review","volume":"2018","author":"de Morais","year":"2018","journal-title":"Int. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27840_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/17512433.2019.1581605","article-title":"Unraveling \u2018The Cancer Genome Atlas\u2019 information on the role of SLC transporters in anticancer drug uptake","volume":"12","author":"Al-Abdulla","year":"2019","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27840_bib14","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1530\/ERC-19-0491","article-title":"Redifferentiation of radioiodine-refractory thyroid cancers","volume":"27","author":"Buffet","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e27840_bib15","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/cancers11091382","article-title":"Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies","volume":"11","author":"Aashiq","year":"2019","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e27840_bib16","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.3390\/ijms22116067","article-title":"MiR-181a-5p regulates NIS expression in papillary thyroid carcinoma","volume":"22","author":"Gierlikowski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e27840_bib17","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1158\/0008-5472.CAN-18-1954","article-title":"A nonpump function of sodium iodide symporter in thyroid cancer via cross-talk with PTEN signaling","volume":"78","author":"Feng","year":"2018","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e27840_bib18","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3390\/genes11080886","article-title":"Nuclear regulation of Wnt\/\u03b2-catenin signaling: it\u2019sa complex situation","volume":"11","author":"Anthony","year":"2020","journal-title":"Genes"},{"issue":"31","key":"10.1016\/j.heliyon.2024.e27840_bib19","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10409","article-title":"Inhibition of canonical WNT\/\u03b2-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e27840_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100066","article-title":"Targeting Wnt\/\u03b2-catenin pathway for drug therapy","volume":"8","author":"Liu","year":"2020","journal-title":"Medicine in Drug Discovery"},{"issue":"48","key":"10.1016\/j.heliyon.2024.e27840_bib21","doi-asserted-by":"crossref","first-page":"24133","DOI":"10.1073\/pnas.1909452116","article-title":"Hepatocyte nuclear factor-1\u03b2 regulates Wnt signaling through genome-wide competition with \u03b2-catenin\/lymphoid enhancer binding factor","volume":"116","author":"Chan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01624-x","article-title":"LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt\/\u03b2-catenin pathway","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep19156","article-title":"A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting \u03b2-catenin\/LEF-1 signaling","volume":"6","author":"Hsieh","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e27840_bib24","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1159\/000491063","article-title":"Repression of WT1-mediated LEF1 transcription by mangiferin governs \u03b2-catenin-independent Wnt signalling inactivation in hepatocellular carcinoma","volume":"47","author":"Tan","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27840_bib25","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.3892\/ol.2017.5788","article-title":"Oct4 induces EMT through LEF1\/\u03b2-catenin dependent WNT signaling pathway in hepatocellular carcinoma","volume":"13","author":"Sun","year":"2017","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e27840_bib26","first-page":"891","article-title":"[Nuclear translocation of \u03b2-catenin represses membrane localization of NIS in human thyroid cancer cells]","volume":"96","author":"Lan","year":"2016","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molcel.2018.07.040","article-title":"Identification of ICAT as an APC inhibitor, revealing Wnt-dependent inhibition of APC-Axin interaction","volume":"72","author":"Ji","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.heliyon.2024.e27840_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-physiol-022516-034125","article-title":"The sodium\/iodide symporter (NIS): molecular physiology and preclinical and clinical applications","volume":"79","author":"Ravera","year":"2017","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e27840_bib29","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/ijms18061247","article-title":"Flavonoids, thyroid iodide uptake and thyroid cancer\u2014a review","volume":"18","author":"Gon\u00e7alves","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e27840_bib30","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1089\/thy.2017.0290","article-title":"Reintroducing the sodium\u2013iodide symporter to anaplastic thyroid carcinoma","volume":"27","author":"Schmohl","year":"2017","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e27840_bib31","doi-asserted-by":"crossref","first-page":"T193","DOI":"10.1530\/ERC-21-0177","article-title":"The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment","volume":"28","author":"Spitzweg","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14712598.2016.1100162","article-title":"The use of the NIS reporter gene for optimizing oncolytic virotherapy","volume":"16","author":"Miller","year":"2016","journal-title":"Expet Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3892\/or.2016.5228","article-title":"Inhibiting \u03b2-catenin expression promotes efficiency of radioiodine treatment in aggressive follicular thyroid cancer cells probably through mediating NIS localization","volume":"37","author":"Lan","year":"2017","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27840_bib34","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3892\/ijo.2016.3659","article-title":"miR-449 overexpression inhibits papillary thyroid carcinoma cell growth by targeting RET kinase-\u03b2-catenin signaling pathway","volume":"49","author":"Li","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e27840_bib35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5152\/j.aott.2020.03.529","article-title":"Effect of kirenol on the interaction between the WNT\/\u03b2-Catenin and RUNX2\/TCF\/LEF1 pathways in fracture healing in vivo","volume":"54","author":"Karaman","year":"2020","journal-title":"Acta Orthop. Traumatol. Turcica"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e27840_bib36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbrc.2020.03.050","article-title":"Echinacoside inhibits breast cancer cells by suppressing the Wnt\/\u03b2-catenin signaling pathway","volume":"526","author":"Tang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e27840_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112830","article-title":"Huoxue decoction improves chronic abacterial prostatitis\/chronic pelvic pain syndrome through activating Wnt\/GSK\u03b2\/\u03b2-catenin signaling pathway and alleviating apoptosis","volume":"149","author":"Yi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e27840_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/CBM-170777","article-title":"LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt\/\u03b2-catenin signaling pathway","volume":"22","author":"Ding","year":"2018","journal-title":"Cancer Biomarkers"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e27840_bib39","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s12094-021-02655-0","article-title":"Mechanisms of regulating NIS transport to the cell membrane and redifferentiation therapy in thyroid cancer","volume":"23","author":"Cai","year":"2021","journal-title":"Clin. Transl. Oncol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e27840_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/genes9040204","article-title":"Wnt signaling in thyroid homeostasis and carcinogenesis","volume":"9","author":"Ely","year":"2018","journal-title":"Genes"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e27840_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-02827-w","article-title":"Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt\/\u03b2-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma","volume":"11","author":"Dai","year":"2020","journal-title":"Cell Death Dis."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e27840_bib42","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1038\/s41388-020-1307-3","article-title":"The \u03b2-catenin\/TCF-4-LINC01278-miR-1258-Smad2\/3 axis promotes hepatocellular carcinoma metastasis","volume":"39","author":"Huang","year":"2020","journal-title":"Oncogene"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024038714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024038714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:23:20Z","timestamp":1782246200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024038714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024038714"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27840","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of sodium\/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the \u03b2-catenin\/LEF-1 pathway","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e27840"}}